Full notification fileGeneral informationNotification NumberB/GB/04/R39/1Member State to which the notification was sentUnited KingdomDate of acknowledgement from the Member State Competent Authority03/02/2004Title of the ProjectStrategies for risk assessment, evaluating the environmental impact of fungal diseases suppressing GM bacteria on non-target speciesProposed period of release:05/04/2004 to 01/10/2004Name of the Institute(s) or Company(ies)Natural Environment Research Council (UK), Centre of Ecology and Hyrology Oxford,
Molecular Microbial Ecology Research Laboratory,
Virology and Environmental Microbiology,
Oxford, OX1 3SR
3. Is the same GMO release planned elsewhere in the Community?NoHas the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:BacteriumIdentity of the GMO:Pseudomonas fluorescensInformation relating to the recipient or parental organisms from wich the GMO is derived
European Commission administrative informationConsent given by the Member State Competent Authority:Yes30/04/2004 00:00:00Remarks:The UK's Advisory Committee on Releases to the Environment has advised that the release of this GM soil bacterium poses a very low risk to human health and the environment. The consent details when and where the trial can take place. It is conditional on monitoring for the GMO throughout the trial site and in adjacent land. Monitoring can only be terminated once the Secretary of State has agreed its design and output. As this is a Part B release, the consent specifies minimum requirements in the design of the trial site so that dispersal of the GMO is minimised.